Biotech firm moved to the Netherlands to make money: "There is a general problem in Europe, but for us the solution was in the Netherlands"

Dutch venture funds are investing millions into Danish biotech companies and are encouraging Danish businesses to look Southwest in their hunt for financing. Allero Therapeutics moved their business to Holland for this reason.

Emil Pot is CEO of Allero Therapeutics, which he co-founded alongside two former ALK executives, Poul Sørensen and Flemming Steen Jensen. Allero has just moved to the Netherlands to secure an investment. Photo: Foto: NLO / PR

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try MedWatch for 14 days.

Get a trial subscription here.

Do you want a trial subscription with multiple users for yourself and your colleagues?

Read more about your options and find the contact information to our sales team here.

Related articles